Honeywell executive sells 873 shares in planned trade

Honeywell International executive Kenneth J. West, Pres/CEO Process Technologies, sold 873 shares of common stock in an open-market transaction at $242.70 per share.

Accepted by SEC EDGAR 03/03/2026 - 04:02 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Honeywell International executive Kenneth J. West, Pres/CEO Process Technologies, sold 873 shares of common stock in an open-market transaction at $242.70 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on November 24, 2025. After the sale, he directly held 3,268 shares and indirectly held 738.5797 shares through a 401(k) plan.

Insider Trade Summary

Net Seller: 873 shares

Net Sell 1 txn

Insider West Kenneth J

Role Pres/CEO Process Technologies

Sold 873 shs ($212K)

Type	Security	Shares	Price	Value
Sale	Common Stock	873	$242.70	$212K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,268 shares (Direct); Common Stock — 738.5797 shares (Indirect, Held in 401(k) plan)

Footnotes (1)

1. F1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Honeywell (HON) report for Kenneth J. West?

Honeywell reported that executive Kenneth J. West sold 873 shares of common stock. The open-market sale was executed at $242.70 per share, according to a prearranged Rule 10b5-1 trading plan adopted on November 24, 2025.

How many Honeywell (HON) shares did Kenneth J. West retain after the reported sale?

After the sale, Kenneth J. West directly held 3,268 Honeywell common shares. He also indirectly held 738.5797 additional shares in a 401(k) plan, reflecting his remaining ownership stake following the 873-share open-market disposition.

At what price were Kenneth J. West’s Honeywell (HON) shares sold?

The 873 Honeywell shares were sold at an average price of $242.70 per share. This open-market transaction, disclosed in the Form 4, reflects a Rule 10b5-1 plan sale rather than a newly decided discretionary trade.

Was the Honeywell (HON) insider sale by Kenneth J. West under a 10b5-1 plan?

Yes. The filing notes the sale was effected under a Rule 10b5-1 trading plan. That plan was adopted by Kenneth J. West on November 24, 2025, providing a prearranged framework for selling Honeywell shares over time.

What is Kenneth J. West’s role at Honeywell (HON) in this Form 4 filing?

In the Form 4, Kenneth J. West is identified as an officer of Honeywell, serving as Pres/CEO Process Technologies. His position makes his share transactions subject to insider reporting requirements for Honeywell’s common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

West Kenneth J

(Last) (First) (Middle)

855 S. MINT STREET

(Street)

CHARLOTTE NC 28202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HONEYWELL INTERNATIONAL INC [ HON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres/CEO Process Technologies

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S(1)		873	D	$242.7	3,268	D
Common Stock								738.5797	I	Held in 401(k) plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2025.

Remarks:

	Richard Kent for Kenneth J. West	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.